Assessment of Drug Utilization Pattern in Chronic Kidney Disease Patients in A Tertiary Care Hospital Based on Who Core Drug Use Indicators
Abstract
Full Text:
PDFReferences
Marriot, J., Cockwell, P., Stringer, S. Chronic kidney disease and end‑stage renal disease. In: Walker R, Whittlesea C, editors. Clinical Pharmacy and therapeutics. UK: Churchill livingstone; 2012. pp.272.
Tsai, W., Wu, H., Peng, Y., Ko, M., Wu, M., Hung, K., et al. Risk factors for development ad progression of chronic kidney disease. Medicine, 2016, 95(11).
Nugent, R. A., Fathima, S. F., Feigel, A. B., Chyung, D. The burden of chronic kidney disease on developing nations: A 21st century challenge in global health. Nephron. Clin. Pract., 2011,118:269-277.
Jha, V., Garcia, c., Iseki, K., Naicker, S., Plattner, B., Saran, R., Wang, A., Yang, C. Chronic kidney disease: global dimension and perspectives. Lancet., 2013, 382:260-272.
Murthy, B., and Satyanarayana, V. Prescribing pattern of drugs in chronic kidney disease patients on hemodialysis at a tertiary care hospital. Int. J Basic. Clin. Pharmacol., 2017, 6(4): 928-932.
Hudson, J. Q., Wazny, L. D. Chronic Kidney Disease. In: DiPiro, J. T., Talbert, R. L., Yee, G. C., et al., eds. Pharmacotherapy: A Pathophysiologic Approach. 7th ed. New York: McGraw-Hill; 2008:pp.634
Roberts, J. A., Lipman, J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit. Care. Med., 2009, 37: 840-51.
Philips, M., Wilson, J. A., Aly, A., An evaluation of medication reconciliation in an outpatient nephrology clinic. Cannt. J., 2017, 26(2):29-33.
Ahlawat, R., D’cruz, S., and Tiwari, P. Drug utilization pattern in chronic kidney disease patients at a tertiary care public teaching hospital: evidence from a cross-sectional study. J. Pharma. Care. Health. Sys. 2015, 3(1).
WHO. The rational use of drugs. Report of a conference expert, Nairobi, 25-29 November 1985. Geneva: World Health Organization; 1987.
Dheepan, B, N., Sarala, N., and Raghavendra, B, N. Drug utilization study in hemodialysis unit in a tertiary care Centre in kolar. Int. Pharm. Bio. Sci., 2015, 5(1):72-78.
Shalini, S., Ravichandran, V., Mohanty, B. K., Dhanaraj, S. K., Saraswathi, R. Drug utilization studies- An overview. International Journal of pharmaceutical sciences and Nanotechnology. 2010, 3(1): 803-810.
How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators - EDM Research Series No. 007: Chapter 2: Core Drug Use Indicators: Prescribing Indicators [Internet]. World health organization.1993 [ cited 5 feb 2019]. Available from http://apps.who.int/medicinedocs/en/d/Js2289e/.
Bharani, K., Bharani, R., Vohra, R., and Goyal, C. Drug utilization pattern of antihypertensive drugs in chronic kidney disease stage 5 patients in a tertiary care hospital of central India. International journal for basic & clinical pharmacology, 2003,7(7):1411-1414.
Abhisek, p., Panda, R., Samal, R.,Mohapatra, N., and Mohanty, S. Dtug utilization pattern and adverse events in patients with chronic kidney disease undergoing maintaenance haemodialysis at a tertiary care hospital of Odisha. Journal of clinical and diagnostic research. 2017,11(10):11-16 .
Bajait, C., Pimpalkhute, S., Sontakke, S., jaiswal, K., and Dawrl, A. Prescribing pattern of medicines in chronic kidney disease with emphasis on phosphate binders. Indian journal of pharmacology, 2014, 46(1): 35-39.
Goldberg, I., Krause, I. The role of gender in chronic kidney disease. Eur. Med. J, 2015,1(2):58-64.
Fesipe, O., Akhideno, P., Nwaiwu, O., and Adelosye, A. Assessment of prescribed medications ans pattern of distribution for potential drug-drug interactions among chronic kidney disease patients attending the Nephrology clinic of Lagos university teaching hospital in sub-Saharan west Africa. Clinical pharmacology: Advances and applications, 2017,9: 125-132.
Cohen, E., Nardi, Y., Krause, I., Goldberg, E., Milo, G., Garty, M., et al.A longitudinal assessment of the natural rate of decline in renal function with age. J Nephrol, 2014,27(6):635-41.
Santra, S., Agrawal, D., Kumar, S., and Mishra, S. A study on the drug utilization pattern in patients with chronic kidney disease with emphasis on antibiotics. J. Nephrol. Androl., 2015, 2(3):85-89.
Kantanavar, K., Holla, R., and Rao, S. A study of prescription pattern in the drug therapy of chronic kidney disease. International journal of pharmacological research., 2017, 7(04): 81-87.
Chakraborty, S., Ghosh, S., Banerjea, A., Raman, R., Hazra, A., and Mandal, S. Prescribing patterns of medicines in chronic kidney disease patients on maintainance hemodialysis. Indian journal of Pharmacology. 2016, 48(5): 586-590.
Swamy, N., Mateti, U., Bairi, R., Sivva, D., ans Martha, S. Drug utilization pattern in south Indian pediatric population: A prospective study. Perspective in clinical research, 2014,5(4):178-183.
Chawla, S., Ranjan, A., Singh, N., Garg, N., and Kumar, A. Assessment of drug utilization and quality of life in patients of chronic kidney disease in a tertiary care hospital. World journal of pharmacy and pharmaceutical scinces., 2016, 5(9): 1214-1226.
National List of Essential Medicines (NLEM) 2015 – India [Internet]. World health organization. 2015 [cited in 21st March 2019]. Available from: http://apps.who.int/medicinedocs/en/m/abstract/Js23088en/.
Kumar, V., Nagesh., and Kumar, G. A prospective study on prevalence, dialysis, and drug utilization of chronic renal failure patients. International Journal of pharmacology research. 2013, 3(2):45-52.
Ahlawat, R., Tiwari, P., and D’Cruz, S. Direct cost for treating chronic kidney disease at an outpatient setting of a tertiary hospital: Evidence from a cross-sectional study. Value in health regional issues. 2017, 12: 36-40.
Refbacks
- There are currently no refbacks.